BridgeMD
New treatment option for Neoplasms
Official title Evaluation of an Interactive E-learning Environment to Enhance Digital Health Literacy in Cancer Patients
ClinicalTrials.gov ID: NCT07200453
What this study is testing
- What it's testing
- This study aims to create and test an online learning tool to help people with cancer improve their skills in finding and understanding health information online. The main question it aims to answer is: Do people with cancer who use the online learning tool improve their skills more than those who don't use the tool?
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- cancer diagnosis
- sufficient knowledge of the German language as all study content and questionnaires will be in German only
- Participants must also have and be able to use a digital device (smartphone, tablet, PC, laptop, etc.) with an internet connection
- Confirm consent to participate in the study
You likely can't join if
- Patients who are severely cognitively impaired due to their cancer or other illness
- Patients who are unable to operate a digital device
The study team makes the final eligibility decision.
Where it's taking place
- Hamburg, Free and Hanseatic City of Hamburg, Germany
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Hamburg, Free and Hanseatic City of Hamburg, Germany. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.